Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › JAK kinase inhibitor compounds for treatment of respiratory disease

JAK kinase inhibitor compounds for treatment of respiratory disease

US Patent 11299492 · Granted Apr 12, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thiadiazolyl derivatives2025
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors2025
Substituted benzenecarboxamides as IL-17A modulators2025
Substituted benzenecarboxamides as IL-17A modulators2025
Bridged tricyclic carbamoylpyridone compounds and uses thereof2025
Dimethyl amino azetidine amides as JAK inhibitors2025
Amino acid compounds and methods of use2025
Imidazolo indazole compounds as JAK inhibitors2025
Methods of treating neurological disorders2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin2025